Escitalopram levels in premenopausal and postmenopausal women
Part of Mental health clinical trials.
This study measures how the antidepressant escitalopram builds up in the blood of women before and after menopause. It aims to see if hormone changes affect drug levels, which could help doctors adjust doses for better treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 40 and 60 years old.
- You have been diagnosed with major depression or generalized anxiety by a doctor not in the research team.
- You have been taking the antidepressant escitalopram for at least one month and on the same dose for at least one week.
- You are willing to join and sign a consent form.
- If you are postmenopausal: you have not had a period for at least one year.
- If you are premenopausal: you have regular periods and are in the luteal phase (14 days after ovulation).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether escitalopram, a common antidepressant, helps people who are experiencing their first episode of depression and have never taken medication for it. It also looks at how the drug works in the brain.
This study tests whether a genetics-guided approach to choosing and adjusting escitalopram (an anxiety medicine) can improve safety and effectiveness for anxious teens. It also checks that participants have certain anxiety severity scores and can safely take the study medication.
This study tests which treatment sequence works best for people with anxiety conditions (generalized, social, separation) and/or panic, who also have significant depression/anxiety symptoms. It may help you find a more effective step-by-step plan and compare treatment orders.
This Phase 4 study tests an “optimized” medication approach for adults with major depressive disorder (unipolar depression) based on how you respond over time. It may help your care team choose treatments more effectively and reduce trial-and-error.
This study tests whether adding a fish oil supplement (CreNeuroS) to the antidepressant escitalopram works better than escitalopram alone for moderate-to-severe depression. You'll take both the supplement and the medication together over the study period.
This study tests how a person's genetic makeup affects their response to the antidepressant escitalopram (Lexapro). It takes place at a community pharmacy and aims to help personalize treatment for depression.
Hear when a new Therapeutic Drug Monitoring (TDM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.